Abstract: Polyenphosphatidylcholine are recommended to improve liver function in several national
guidelines based on the clinical evidence which showed that polyenphosphatidylcholine were effective in
patients with multiple liver diseases. Due to the limited description of data on polyenphosphatidylcholine in
previous guidelines, the comprehensive review of polyenphosphatidylcholine in patients with liver diseases
is needed. The committee of the treatment with polyenphosphatidylcholine in patients with liver diseases
published the present consensus to standardize the clinical use of polyenphosphatidylcholine in patients with
liver diseases.